Related Experiment Video
Updated: May 3, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease
Published on: June 16, 2020
High-resolution CT scoring system-based grading scale predicts the clinical outcomes in patients with idiopathic
Keishi Oda, Hiroshi Ishimoto, Kazuhiro Yatera
1Department of Respiratory Medicine, University of Occupational and Environmental Health, Japan, 1-1, Iseigaoka, Yahatanishiku, Kitakyushu City, Fukuoka 807-8555, Japan. hmukae@med.uoeh-u.ac.jp.
Insights
A new high-resolution computed tomography (HRCT) scoring system helps predict idiopathic pulmonary fibrosis (IPF) outcomes. This tool identifies patients with poor prognosis, aiding clinical management when combined with spirometry.
Area of Science:
- Pulmonology
- Radiology
- Medical Diagnostics
Background:
- Idiopathic pulmonary fibrosis (IPF) diagnosis relies on high-resolution computed tomography (HRCT).
- The prognostic value of HRCT scoring systems, based on established grading scales, requires further investigation.
- This study retrospectively assessed the prognostic utility of a novel HRCT scoring system in IPF patients.
Purpose of the Study:
- To evaluate the prognostic value of changes in HRCT findings using a new HRCT scoring system.
- To determine if the HRCT fibrosis score can predict clinical outcomes in IPF.
- To identify IPF patients with an adverse prognosis.
Main Methods:
- Retrospective analysis of 98 IPF patients diagnosed via HRCT.
- Serial HRCT and pulmonary function tests conducted at six-month intervals for one year.
- Evaluation of HRCT findings using a new HRCT fibrosis scoring system and Kaplan-Meier survival analysis.
Main Results:
- HRCT fibrosis scores significantly increased at six and 12 months post-diagnosis (p < 0.001).
- An elevated HRCT fibrosis score at six months predicted a poor prognosis (HR 2.435, p = 0.0142).
- Patients with an elevated score and stable %FVC also showed a poor prognosis (HR 2.192, p = 0.0491).
Conclusions:
- The HRCT scoring system, based on the grading scale, is a valuable tool for predicting IPF clinical outcomes.
- This scoring system aids in identifying IPF patients with an adverse prognosis.
- Combining the HRCT scoring system with spirometry enhances prognostic accuracy in IPF management.
Background:
The 2011 idiopathic pulmonary fibrosis (IPF) guidelines are based on the diagnosis of IPF using only high-resolution computed tomography (HRCT). However, few studies have thus far reviewed the usefulness of the HRCT scoring system based on the grading scale provided in the guidelines. We retrospectively studied 98 patients with respect to assess the prognostic value of changes in HRCT findings using a new HRCT scoring system based on the grading scale published in the guidelines.
Methods:
Consecutive patients with IPF who were diagnosed using HRCT alone between January 2008 and January 2012 were evaluated. HRCT examinations and pulmonary function tests were performed at six-month intervals for the first year after diagnosis. The HRCT findings were evaluated using the new HRCT scoring system (HRCT fibrosis score) over time. The findings and survival rates were analyzed using a Kaplan-Meier analysis.
Results:
The HRCT fibrosis scores at six and 12 months after diagnosis were significantly increased compared to those observed at the initial diagnosis (p < 0.001). The patients with an elevated HRCT fibrosis score at six months based on a receiver operating characteristic (ROC) curves analysis had a poor prognosis (log-rank, hazard ratio [HR] 2.435, 95% CI 1.196-4.962; p = 0.0142). Furthermore, among the patients without marked changes in %FVC, those with an elevated score above the cut-off value had a poor prognosis (HR 2.192, 95% CI 1.003-4.791; p = 0.0491).
Conclusions:
Our data demonstrate that the HRCT scoring system based on the grading scale is useful for predicting the clinical outcomes of IPF and identifying patients with an adverse prognosis when used in combination with spirometry.
More Related Videos
03:38Unilateral Lung Volume Analysis Using Micro-CT for Enhanced Assessment of Pulmonary Fibrosis in Preclinical Models
Published on: June 20, 2025
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
Related Concept Videos
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History